Teisserenc H - Search Results

1

IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.

Sewell AK, Price DA, Teisserenc H, Booth BL Jr, Gileadi U, Flavin FM, Trowsdale J, Phillips RE, Cerundolo V. Sewell AK, et al. Among authors: teisserenc h. J Immunol. 1999 Jun 15;162(12):7075-9. J Immunol. 1999. PMID: 10358150

2

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.

Dunbar PR, Chen JL, Chao D, Rust N, Teisserenc H, Ogg GS, Romero P, Weynants P, Cerundolo V. Dunbar PR, et al. Among authors: teisserenc h. J Immunol. 1999 Jun 15;162(12):6959-62. J Immunol. 1999. PMID: 10358133

3

A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway.

Teisserenc H, Schmitt W, Blake N, Dunbar R, Gadola S, Gross WL, Exley A, Cerundolo V. Teisserenc H, et al. Immunol Lett. 1997 Jun 1;57(1-3):183-7. doi: 10.1016/s0165-2478(97)00072-2. Immunol Lett. 1997. PMID: 9232449

4

Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway.

Noakes KL, Teisserenc HT, Lord JM, Dunbar PR, Cerundolo V, Roberts LM. Noakes KL, et al. Among authors: teisserenc ht. FEBS Lett. 1999 Jun 18;453(1-2):95-9. doi: 10.1016/s0014-5793(99)00609-2. FEBS Lett. 1999. PMID: 10403383 Free article.

5

Detection of empty HLA class II molecules on cord blood B cells.

Garban F, Ericson M, Roucard C, Rabian-Herzog C, Teisserenc H, Sauvanet E, Charron D, Mooney N. Garban F, et al. Among authors: teisserenc h. Blood. 1996 May 1;87(9):3970-6. Blood. 1996. PMID: 8611729 Free article.

6

[Molecular and cellular bases of antigen presentation and autoimmunity].

Charron D, Ju LY, Teisserenc H, Loiseau P, Lotteau V. Charron D, et al. Among authors: teisserenc h. Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):269-72. Nouv Rev Fr Hematol (1978). 1993. PMID: 8337142 Review. French. No abstract available.

7

[Molecular and cellular bases of the presentation of antigen and autoimmunity].

Charron D, Ju L, Teisserenc H, Loiseau P, Lotteau V. Charron D, et al. Among authors: teisserenc h. C R Seances Soc Biol Fil. 1994;188(1):5-10. C R Seances Soc Biol Fil. 1994. PMID: 7994630 French. No abstract available.

8

PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.

Padua RA, Larghero J, Robin M, le Pogam C, Schlageter MH, Muszlak S, Fric J, West R, Rousselot P, Phan TH, Mudde L, Teisserenc H, Carpentier AF, Kogan S, Degos L, Pla M, Bishop JM, Stevenson F, Charron D, Chomienne C. Padua RA, et al. Among authors: teisserenc h. Nat Med. 2003 Nov;9(11):1413-7. doi: 10.1038/nm949. Epub 2003 Oct 19. Nat Med. 2003. PMID: 14566333

9

Typing alleles of HLA-DM.

Teisserenc H. Teisserenc H. Methods Mol Biol. 2003;210:237-46. doi: 10.1385/1-59259-291-0:237. Methods Mol Biol. 2003. PMID: 12412458 No abstract available.

10

Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma.

Mourah S, Porcher R, Battistella M, Kerob D, Guillot B, Jouary T, Agbalika F, Morinet F, Furlan V, Teisserenc HM, Dupin N, Lebbé C. Mourah S, et al. Among authors: teisserenc hm. Br J Dermatol. 2015 Nov;173(5):1284-7. doi: 10.1111/bjd.13897. Epub 2015 Aug 19. Br J Dermatol. 2015. PMID: 25970141 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters